Trial information
Prevention of Recurrent Hepatitis B After Liver Transplantation
Status: Completed
Protocol number: MCT00059267
Company division: Diagnostic
Official Scientific Title: Prevention of recurrent hepatitis B after liver transplantation
Brief summary: This study is designed to determine risk factors for recurrent HBV post-liver transplantation, and to determine optimal prophylactic therapy to prevent HBV recurrence.
Study type: Interventional; Non-Randomized; Open Label; Uncontrolled; Single Group study
Condition: Hepatitis B, Chronic
Intervention type: Diagnostic Test
Intervention name: CA HBV MONITOR RUO
Inclusion criteria:
Patients awaiting, or having received, liver or combined liver-kidney transplantation for hepatitis B cirrhosis, hepatitis B liver cancer and fulminant hepatitis B
Gender: Males or Females
Age limits: Min: 13 Years Max: 100 Years
Anticipated start date: January, 2002
Trial registration date: 03/17/2006
Date last updated: 9/29/2008
Link to trial result
This trial was conducted at the following locations:
United States
- Los Angeles, CA
- San Francisco, CA
- Stanford, CA
- Miami, FL
- New Orleans, LA
- Boston, MA
- Ann Arbor, MI
- New York, NY
- Rochester, NY
- Philadelphia, PA
- Charlottesville, VA
- Richmond, VA
